L18: Basic Molecular pathology Flashcards

1
Q

What are two methods for removing tissue from a lung?

A

Bronchoscopy–> Camera into airways–> bronchus–> into lung–> take small piece of tumour
CT guided biopsy–> Needle inserted into lesions using CT scan as guide–> remove some of lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the lung molecule markers that are looked for?

A
PDL1
EGFR
Kras
BRAF
MET
Ros1
ALK
All markers of adenocarcinoma 
Certain mutations lead to certain types of cancers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the causes of lung adenocarcinomas?

A

2/3 mutation in oncogenes

1/3 tumour suppressor genes (p53 and Rb)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What sort of oncogenic mutations can occur?

A

MET, (KRAS, EGFR, BRAF, HER2, PIK3CA) mutations

ALK, ROS1 (RET), gene rearrangements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What sort of tumour suppressor mutations can occur?

A

p53 mutation is seen in 50% of NSCLC and 80% small cell lung cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are immunotherapies?

A

Type of treatment designed to boost the bodies defences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give an example of an immunotherapy used?

A

Inhibit PDL1 (programmed death) ligand (high on cancer cells so can usually trick the immune system and avoid being attacked) or its receptor
Using monoclonal antibodies
Reverse T cell exhaustion and results in activation of host anti-tumour immune response
Nivolumab/ Pembrolizumab against PD-1 R
Atezolizumab and Duralumba against PDL1 (ligand)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do cancer cell remain alive?

A

Mutation in

  • Proto-oncogenes to oncogenes so results in proliferation
  • Mutate Ts genes (double hit)
    1. Overexpress anti-apoptotic factors–> inhibit apoptosis
    2. Inhibit pro-apoptotic signals –> p53 and caspases–> uncontrolled proliferation, no repair if DNA damaged
    3. Over express growth factors and/or growth factor receptors
    4. Mutate DNA repair mechanisms (MLH and MSH)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do growth factors increase cancer survival? Give examples of some growth factors?

A

Growth factors help the cells stay alive and proliferate
Low requirement for growth factors (don’t need much to produce a response)
PDGF–> platelet derived growth factor–> angiogenesis and stromal proliferation
TGF beta–> transforming growth factor–> angiogenesis, interaction with lymphocytes and macrophages (supress immune system response) and production of extracellular matrix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What growth factor receptors can lead to cancer formation?

A

Tyrosine kinase receptor–> EGFR, c-erb B2
EGFR expressed on epithelial cells: amplified and thus overexpressed in lung SqCC, Adenocarcinomas and breast cancers
ERB B2–> R gene amplification and overexpressed–> breast cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What can be used to treat cancers caused by over expression on EGFR?

A

Anti EGFR drugs such as afatinib, gefitinib, erlotinib (all the -tinibs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What drug is used to treat cancers caused by ERB B2?

A

Herceptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What targetted drugs do we have for lung adenocarcinomas?

A

Anti EGFRs, anti ALK, anti B-Raf

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why are lymph nodes looked at?

A

To see if the tumour has metastasised to anywhere
Lymph nodes because of lymphatic drainage
Lymph nodes can be removed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is used to detect a melanoma?

A

A- asymmetry–> is it asymmetrical?
B- border–> does it have a irregular border?
C- colour–> is it all one colour
D- diameter–> how big is it?
E- evolution–> has it evolved? over how long?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What markers are commonly seen in melanomas?

A

Most melanomas:
NRAS (15%) and BRAF (45%) (V600E)
leads to activation of MAPK pathway (mitogen activated protein pathway)
Different ones for mucosal melanomas and acral (hand and feet)

17
Q

How do BRAF and NRAS lead to melanoma?

A

Part of MAPK (mitogen activated protein kinase pathway)
NRAS activates BRAF
BRAF activates signalling pathway (MEK) leads to transcription of DNA –> cell proliferation and survival

18
Q

What treatments are available for BRAF and NRAS melanomas?

A

Anti BRAF–> Dabranfenib, Tramtinib
Inhibit BRAF preventing activation of pathway
However tumour resistance can develop on 6 months on selective BRAF inhibitors alone

19
Q

What immunotherapies are used to treat melanomas?

A

Disease lacking BRAF mutation
PD-1 (receptors) binds to PDL1 (ligand) –> inhibits T cell proliferation meaning T cells can’t destroy cancer cells
PDL1 widely expressed on tumour cells
Block PDL1 ligand from binding to receptor–> T cells can restore normal function
Increase cytokine production
Cytolyisis of cells

20
Q

What medications are prescribe as immunotherapies?

A

Nivolumab and Pembrolizumab (Againt PD1- R)

21
Q

What other cancers are also developing personalised treatments?

A

Metostatic urothelial carcinoma - PDL1

Colorectal cancer- DNA mismatch repair enzymes